Bullish Moving Averages
10
Bearish Moving Averages
6
Back Stocks profile
Stock analysis tool for investors
Performance
Today’s low
37.00Today’s High
37.6052W low
30.1052W High
61.50Open Price
37.00Prev. Close
37.0000Volume
9689.00Value
360237.02Fundamentals
Market Cap
37.20
Price to Earnings
4076.80
Price to Book Value
1.10
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM
47.64
Net Profit TTM
0.01
Cash From Operating Activity
0.79
Return on Equity %
1.39
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
26 Sep, 2024
86.7
Week
91.1
Month
79.2
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
37.25
PIVOT
First Resistance
37.55
Second Resistance
37.92
Third Resistance
38.22
First Support
36.88
Second Support
36.58
Third Support
36.21
Relative Strength Index
51.66
Money Flow Index
45.76
MACD
0.05
MACD Signal
0.11
Average True Range
1.75
Average Directional Index
14.1
Rate of Change (21)
2.57
Rate of Change (125)
7.86
Day Commodity Channel Index
-17.2
Day Williams %R
-46.2
BETA
1 Month
0.77
3 Month
0.35
1 Year
0.67
3 Year
0.46
PRICE CHANGE ANALYSIS
↑ 0.84%
1 Week
Low
High
35.06
38.8
↑ 1.09%
1 Month
Low
High
35.06
39.31
↓ -0.77%
3 Months
Low
High
30.59
44.96
↑ 7.02%
6 Months
Low
High
30.59
44.96
↑ 9.87%
1 Year
Low
High
30.06
61.5
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 6.35 | 14.47 | 12.62 | 7.39 | 8.79 | 11.54 | 13.53 | 13.72 | 12.54 | 15.49 | 13.47 | 9.86 | 20.24 | |
| Operating Expenses Qtr | 5.62 | 14.28 | 12.06 | 5.85 | 7.39 | 10.80 | 12.08 | 12.53 | 11.56 | 14.81 | 12.41 | 8.19 | 17.95 | |
| Operating Profit Qtr | 0.73 | 0.19 | 0.56 | 1.53 | 1.40 | 0.74 | 1.44 | 1.19 | 0.97 | 0.66 | 1.03 | 1.67 | 2.27 | |
| EBIDT Qtr Cr | 0.73 | 0.19 | 0.56 | 1.54 | 1.40 | 0.74 | 1.44 | 1.19 | 0.98 | 0.68 | 1.06 | 1.67 | 2.29 | |
| Depreciation Qtr | 0.34 | 0.39 | 0.38 | 0.38 | 0.38 | 0.31 | 0.38 | 0.53 | 0.39 | 0.37 | 0.30 | 0.57 | 0.53 | |
| Net Profit Qtr | 0.01 | -0.35 | -0.24 | 0.53 | 0.49 | 0.07 | 0.45 | 0.18 | 0.19 | 0.03 | 0.42 | 0.46 | 0.69 | |
| Basic EPS Qtr | 0.01 | -0.35 | -0.24 | 0.56 | 0.52 | 0.07 | 0.52 | 0.21 | 0.21 | 0.03 | 0.48 | 0.52 | 0.79 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 43.27 | 51.32 | 59.06 | 51.45 | 51.46 | |
| Operating Expenses Annual Cr | 39.58 | 46.97 | 53.36 | 48.14 | 47.99 | |
| Operating Profit Annual | 3.68 | 4.34 | 5.59 | 3.22 | 3.34 | |
| Operating Profit Margin Annual % | 8.50 | 8.46 | 9.47 | 6.26 | 6.50 | |
| Total Expenses Annual Cr | 42.71 | 50.20 | 56.81 | 50.92 | 51.00 | |
| EBIDT Annual Cr | 3.69 | 4.35 | 5.69 | 3.31 | 3.46 | |
| EBIDT Annual margin % | 8.52 | 8.48 | 9.64 | 6.44 | 6.73 | |
| Depreciation | 1.54 | 1.60 | 1.76 | 1.37 | 1.46 | |
| PAT Before ExtraOrdinary Items Annual Cr | 0.42 | 0.89 | 1.59 | 3.28 | 0.33 | |
| Net Profit Annual | 0.42 | 0.89 | 1.59 | 3.28 | 0.33 | |
| Basic EPS Annual | 0.42 | 0.96 | 1.82 | 3.75 | 0.38 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 33.82 | 31.70 | 28.36 | 26.77 | 23.48 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 3.04 | 4.03 | 5.23 | 3.73 | 3.55 | |
| Total Current Liabilities Annual Cr | 19.44 | 20.90 | 22.86 | 19.38 | 30.98 | |
| Total Capital Plus Liabilities Annual Cr | 56.30 | 56.63 | 56.45 | 49.88 | 58.02 | |
| Fixed Assets Annual | 13.26 | 13.78 | 14.52 | 13.83 | 11.52 | |
| Total Non Current Assets Annual | 14.92 | 15.23 | 32.04 | 13.87 | 12.45 | |
| Total Current Assets Annual | 41.38 | 41.40 | 24.40 | 36.01 | 45.56 | |
| Total Assets Annual | 56.30 | 56.63 | 56.45 | 49.88 | 58.02 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 1.96 | 2.24 | 0.77 | 1.62 | 2.16 | |
| Cash from Investing Activity Annual | -1.21 | -2.27 | 0.01 | -3.67 | -0.84 | |
| Cash from Financing Annual Activity | -0.69 | 0.05 | 1.68 | 2.07 | -1.46 | |
| Net Cash Flow Annual | 0.06 | 0.03 | 2.47 | 0.02 | -0.15 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 33.82 | 34.03 | 32.44 | 30.61 | 26.86 | |
| ROE Annual % | 1.24 | 2.81 | 5.62 | 12.26 | 1.39 | |
| ROCE Annual % | 5.82 | 7.69 | 11.69 | 6.39 | 7.39 | |
| Total Debt to Total Equity Annual | 0.41 | 0.47 | 0.58 | 0.48 | 0.41 | |
| EBDIT Annual Margin % | 8.52 | 8.48 | 9.65 | 6.45 | 6.74 |
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Sep 2022 | Jun 2022 | Graph |
|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 11.69 | 15.64 | 12.78 | 7.52 | 8.98 | 13.72 | 12.54 | |
| Operating Expenses Qtr | 10.86 | 15.29 | 12.15 | 5.91 | 7.52 | 12.53 | 11.56 | |
| Operating Profit Qtr | 0.83 | 0.35 | 0.63 | 1.60 | 1.46 | 1.19 | 0.97 | |
| EBIDT Qtr Cr | 0.83 | 0.35 | 0.63 | 1.61 | 1.46 | 1.19 | 0.98 | |
| Depreciation Qtr | 0.34 | 0.39 | 0.39 | 0.39 | 0.38 | 0.53 | 0.39 | |
| Net Profit Qtr | 0.03 | -0.34 | -0.24 | 0.56 | 0.49 | 0.18 | 0.19 | |
| Basic EPS Qtr | 0.03 | -0.34 | -0.24 | 0.60 | 0.53 | 0.21 | 0.21 |
| Indicator | Mar 2024 | Mar 2023 | Graph |
|---|---|---|---|
| Total Revenue Annual | 44.93 | 52.09 | |
| Operating Expenses Annual Cr | 40.88 | 47.51 | |
| Operating Profit Annual | 4.04 | 4.57 | |
| Operating Profit Margin Annual % | 9.00 | 8.78 | |
| Total Expenses Annual Cr | 44.30 | 50.84 | |
| EBIDT Annual Cr | 4.05 | 4.58 | |
| EBIDT Annual margin % | 9.02 | 8.79 | |
| Depreciation | 1.56 | 1.63 | |
| PAT Before ExtraOrdinary Items Annual Cr | 0.47 | 0.99 | |
| Net Profit Annual | 0.47 | 0.99 | |
| Basic EPS Annual | 0.47 | 1.06 |
| Indicator | Mar 2024 | Mar 2023 | Graph |
|---|---|---|---|
| Total ShareHolders Funds Annual | 33.82 | 31.70 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 3.65 | 4.91 | |
| Total Current Liabilities Annual Cr | 21.34 | 21.61 | |
| Total Capital Plus Liabilities Annual Cr | 58.81 | 58.23 | |
| Fixed Assets Annual | 13.31 | 13.84 | |
| Total Non Current Assets Annual | 14.19 | 14.77 | |
| Total Current Assets Annual | 44.62 | 43.46 | |
| Total Assets Annual | 58.81 | 58.23 | |
| Contingent Liabilities plus Commitments Annual Cr | - | - |
| Indicator | Mar 2024 | Mar 2023 | Graph |
|---|---|---|---|
| Cash from Operating Activity Annual | 0.79 | 1.66 | |
| Cash from Investing Activity Annual | -1.01 | -2.27 | |
| Cash from Financing Annual Activity | 0.28 | 0.62 | |
| Net Cash Flow Annual | 0.07 | 0.02 |
| Indicator | Mar 2024 | Mar 2023 | Graph |
|---|---|---|---|
| Book Value Per Share Annual | 33.82 | 34.03 | |
| ROE Annual % | 1.39 | 3.10 | |
| ROCE Annual % | 6.66 | 8.07 | |
| Total Debt to Total Equity Annual | 0.49 | 0.51 | |
| EBDIT Annual Margin % | 9.01 | 8.79 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| NAGI REDDY SEELAM | 29.13 | 89076511 | 0 | 31.52 |
| S. MANOJ KUMAR REDDY | 16.28 | 89076512 | 0 | 51.72 |
| SEELAM KONI REDDY | 10 | 89076513 | 0 | 17.8 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| RAJENDER KUMAR AGARWAL | 1.69 | 89076518 |
| MANJU AGARWAL | 1.3 | 89076519 |
| SUSHIL KUMAR AGARWAL | 1.3 | 89076520 |
| S N THULASI DEVI | 1.21 | 89076521 |
| K RAMESH REDDY | 1.05 | 89076522 |
| EKTA VIJAYWARGI | 1 | 89076523 |
| MOHAN THODUPUNURI | 1 | 89076524 |
| RAKESH K | 1 | 89076525 |
| SANNUTHI LOKESH | 1 | 89076526 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| Aug 09, 2024 | Quarterly Results | - |
| May 30, 2024 | Audited Results | (Revised) |
| Feb 13, 2024 | Quarterly Results | - |
| Nov 14, 2023 | Quarterly Results | - |
| Aug 14, 2023 | Quarterly Results | - |
| May 30, 2023 | Audited Results | - |
| Feb 14, 2023 | Quarterly Results | - |
| Nov 14, 2022 | Quarterly Results | - |
| Aug 06, 2022 | Quarterly Results | - |
| May 30, 2022 | Audited Results | - |
| Feb 14, 2022 | Quarterly Results | - |
| Oct 18, 2021 | Quarterly Results | - |
| Aug 13, 2021 | Quarterly Results | - |
| Jun 28, 2021 | Audited Results | - |
| Feb 13, 2021 | Quarterly Results | - |
| Nov 13, 2020 | Quarterly Results | - |
| Sep 14, 2020 | Quarterly Results | - |
| Jun 27, 2020 | Audited Results | - |
| Feb 13, 2020 | Quarterly Results | - |
| Nov 14, 2019 | Quarterly Results | - |
| Aug 14, 2019 | Quarterly Results | (Revised) |
| Aug 13, 2019 | Quarterly Results | - |
| May 30, 2019 | Audited Results | - |
| Feb 14, 2019 | Quarterly Results | (Revised) |
| Feb 13, 2019 | Quarterly Results | - |
| Nov 14, 2018 | Quarterly Results | - |
| Aug 14, 2018 | Unaudited Financial Results | - |
| May 30, 2018 | Audited Results | - |
| Feb 14, 2018 | Quarterly Results | (Revised) |
| Feb 13, 2018 | Quarterly Results | - |
| Dec 14, 2017 | Quarterly Results | (Revised) |
| Nov 15, 2017 | Others | - |
| Sep 02, 2017 | Quarterly Results | - |
| Aug 28, 2017 | Quarterly Results | - |
| May 30, 2017 | Audited Results | - |
| Feb 14, 2017 | Quarterly Results | - |
| Nov 14, 2016 | Quarterly Results | - |
| Aug 13, 2016 | Quarterly Results | - |
| Jul 07, 2016 | Restructuring of the Board | - |
| Feb 13, 2016 | Quarterly Results | - |
| Nov 14, 2015 | Quarterly Results | - |
| Aug 14, 2015 | Audited Results | - |
| May 30, 2015 | Audited Results | - |
| Mar 30, 2015 | Others | 1. Appointment of Ms. P. Chandra Kala as Woman Director. 2.Redesignation of Mr. Koni Reddy as Director & CFO. |
| Ex-Date | Bonus Ratio | Record Date |
|---|
12 Sep 2024
Concord Drugs Ltd - 538965 - Financial Results For Q1 JUNE 2024
Financial Results for Q1, JUNE 2024
10 Sep 2024
Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication regarding 29th AGM Notice that to be held on 30.09.2024 at 09:45 AM.
06 Sep 2024
Concord Drugs Ltd - 538965 - Reg. 34 (1) Annual Report.
Annual report for year 2023-2024.
06 Sep 2024
Concord Drugs Ltd - 538965 - Book Closure.
Book Closure for purpose of 29th AGM Shall be from 24.09.2024 to 30.09.2024 (both dates Inclusive)
06 Sep 2024
Concord Drugs Ltd - 538965 - Annual General Meeting To Be Held On 30.09.2024
29th Annual general Meeting to be held on 30.09.2024 at 09:45 Am .
06 Sep 2024
Concord Drugs Ltd - 538965 - Board Meeting Outcome for Outcome Of Board Meeting
Out Come of Board Meeting .
02 Sep 2024
Concord Drugs Ltd - 538965 - Board Meeting Intimation for Meeting To Be Held On 06.09.2024.
Concord Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2024 ,inter alia, to consider and approve Increase in Authorized Capital, Proposal for Issue of Preferential Issue of Shares, Other business if any.
11 Aug 2024
Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed newspaper publication on the Unaudited (Standalone and Consolidated) financial results for quarter ended 30th June 2024.
09 Aug 2024
Concord Drugs Ltd - 538965 - Re-Submission Of Financial Results For Year/Quarter Ended 31.03.2024
Submission of financial results for year/quarter ended 31.03.2024 after rectification .
09 Aug 2024
Concord Drugs Ltd - 538965 - Board Meeting Outcome for Outcome Of Board Meeting
Submission of Financial Results for Quarter ended 30.06.2024
